There is good news for the parents of those kids have been suffering from leukemia. It has been found by the British researchers that a drug made by using GlaxoSmithKline could save millions of children’s life.

Reports revealed that scientists have warned regarding a huge financial and social impact as the fear of expense in on the rise.

There are many drug companies who have pulled out from a brain disorder research, which have left without hope and this is believed to have a huge financial crisis on the society. Senior scientists have warned the society to become prepared for the financial crisis.

Drug companies like GlaxoSmithKline and AstraZeneca claimed that they would not be funding the research work anymore on the new antidepressant drugs.

Brain disorders were definitely not less troubling for many families that a new problem has arisen to make the things more complicated for the people. This time drug firms have lead the threat as they have decided to pull out from the researches regarding brain disorder, which can definitely affect many severely and moreover, will also have a big financial impact on the society.

Reports have suggested that European Medicines Agency’s Committee for Medicinal Products for Human Use has been approved. So this is good news for companies like GlaxoSmithKline, Merck & Co, Bristol-Myers Squibb and Amgen, as well as Astellas and Biogen Idec.

It has been reported that due to its anti-diabetic drug called Avandia, a multi-district litigation amounting to an estimated $3.4 billion, will be faced by GlaxoSmithKline.

Reports also state that in different states of America, a number of pending litigations against Avandia have been filed. It is suppose to be an oral anti-diabetic agent which acts primarily by increasing insulin sensitivity.

In 2002, drug maker GlaxoSmithKline PLC had sent across quality-assurance managers, Cheryl Eckard, to Puerto Rico to aid in cleaning the heap of mess that gathered around its biggest manufacturing plants. U. S. authorities claimed for certain violations, which aimed at contaminated ointment implemented for treating skin infections on children.

A top company executive of British drug maker GlaxoSmithKline, GSK, said that at the company’s manufacturing facility in Nasik and Cape Town, an attempt will be made to increase the capacity to make a drug for the treatment of elephantiasis.

GSK at its production units in Nasik and Cape Town makes albendazole that is used by about 120 million people across the world.